| |
| |
|
| Insider
Information: |
Mccourt Marion |
| Relationship: |
EVP Commercial |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,931 |
|
|
Indirect Shares
|
174 |
|
|
| Direct
Value |
$12,721,518 |
|
|
|
Indirect Value
|
$171,181 |
|
|
| Total
Shares |
13,105 |
|
|
| Total
Value |
$12,892,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 30.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Operating Officer |
2016-09-28 |
0 |
2016-02-03 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Commercial |
2024-05-01 |
12,931 |
2024-05-01 |
174 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDVN |
Medivation Inc |
Chief Operating Officer |
• – – |
2016-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
40,453 |
40,453 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-01-03 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
23,179 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-01 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
23,179 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-07 |
4 |
OE |
$372.46 |
$372,460 |
D/D |
1,000 |
23,079 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,973 |
22,079 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-01-03 |
4 |
AS |
$721.86 |
$794,046 |
D/D |
(1,100) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-01 |
4 |
AS |
$752.19 |
$827,409 |
D/D |
(1,100) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-07 |
4 |
S |
$769.04 |
$769,040 |
D/D |
(1,000) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-03-01 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
21,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-04-03 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
21,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,133 |
21,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-10-02 |
4 |
OE |
$372.46 |
$386,613 |
D/D |
1,038 |
20,841 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-11 |
4 |
AS |
$838.44 |
$226,379 |
D/D |
(270) |
20,814 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-12 |
4 |
D |
$751.78 |
$959,271 |
D/D |
(1,276) |
20,803 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-03-01 |
4 |
AS |
$759.89 |
$835,879 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-04-03 |
4 |
AS |
$818.80 |
$900,680 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-11-01 |
4 |
OE |
$381.40 |
$381,400 |
D/D |
1,000 |
20,803 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-05-02 |
4 |
OE |
$342.93 |
$377,223 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-06-01 |
4 |
OE |
$342.93 |
$377,223 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-07-01 |
4 |
OE |
$342.93 |
$377,223 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-08-01 |
4 |
OE |
$342.93 |
$377,223 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-09-01 |
4 |
OE |
$342.93 |
$377,223 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-11-01 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-12-01 |
4 |
OE |
$372.46 |
$409,706 |
D/D |
1,100 |
20,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-01-03 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
20,644 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
